Skip to main content

Want a detailed portfolio tracker?

Forte Biosciences (FBRX) P/E (2020 - 2026)

Forte Biosciences (FBRX) P/E from Jun 30, 2020 to Jun 3, 2026. The TTM Forte Biosciences (FBRX) P/E is -8.88. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Forte Biosciences (FBRX)

YearP/EChange
2026-8.88-37.66%
2025-14.24-29.86%
2024-20.31+577.73%
2023-3.00-90.91%
2022-32.97-53.27%
2021-70.56-94.12%
2020-1.20KN/A

Comparison Forte Biosciences (FBRX) P/E with competitors

Forte Biosciences (FBRX) P/E is -8.88.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-101.15%
ENLVEnlivex Therapeutics Ltd0.15-101.69%
FGENFibroGen Inc0.24-102.70%
TRAWTraws Pharma Inc0.47-105.32%
FBIOFortress Biotech Inc0.71-107.95%
CHRSCoherus Biosciences Inc0.98-111.02%
ORMPOramed Pharmaceuticals Inc1.47-116.59%
AGENAgenus Inc2.05-123.07%
VIVSVivoSim Labs Inc2.54-128.56%
INVAInnoviva Inc3.19-135.91%
CRMDCorMedix Inc3.65-141.06%
ABEOAbeona Therapeutics Inc4.20-147.36%
VXRTVaxart Inc4.26-147.99%
CVACCureVac N.V.4.45-150.07%
SRPTSarepta Therapeutics Inc4.62-152.08%
GLPGGalapagos NV4.86-154.72%
RIGLRigel Pharmaceuticals4.92-155.40%
ZVRAZevra Therapeutics Inc4.97-156.02%
ABUSArbutus Biopharma Corp5.69-164.12%
CGENCompugen Ltd7.38-183.16%
AUPHAurinia Pharmaceuticals Inc9.25-204.19%
ACADAcadia Pharmaceuticals Inc9.59-207.98%
OMEROmeros Corporation9.88-211.31%
PLXProtalix BioTherapeutics Inc9.91-211.59%
SPROSpero Therapeutics Inc10.73-220.89%
ADMAAdma Biologics Inc11.33-227.60%
SVASinovac Biotech Ltd11.44-228.79%
TBPHTheravance Biopharma Inc11.78-232.63%
HRMYHarmony Biosciences Holdings Inc12.18-237.17%
TGTXTG Therapeutics Inc13.18-248.42%
INCYIncyte Corp13.38-250.71%
SABSSAB Biotherapeutics Inc14.06-258.32%
XOMAXOMA Corp14.95-268.31%
REGNRegeneron Pharmaceuticals Inc14.98-268.71%
PBYIPuma Biotechnology Inc15.05-269.50%
EXELExelixis Inc15.79-277.88%
NAGENiagen Bioscience Inc16.35-284.19%
CPRXCatalyst Pharmaceuticals Inc17.34-295.33%
MDXGMimedx Group Inc17.38-295.68%
ARGXArgen X SE23.07-359.83%
HALOHalozyme Therapeutics Inc23.20-361.28%
XOMAOXOMA Corp25.34-385.43%
VRTXVertex Pharmaceuticals Inc25.66-388.93%
XOMAPXOMA Corp25.67-389.09%
CTMXCytomX Therapeutics Inc25.70-389.41%
ASNDAscendis Pharma A/S26.35-396.80%
RPRXRoyalty Pharma plc - Class A27.50-409.65%
SLNOSoleno Therapeutics Inc29.02-426.77%
LGNDLigand Pharmaceuticals Inc - Class B30.19-439.96%
BMRNBiomarin Pharmaceutical Inc37.51-522.40%
APLSApellis Pharmaceuticals Inc39.02-539.45%
KRYSKrystal Biotech Inc39.70-547.07%
GMABGenmab40.20-552.77%
ONCBeiGene Ltd67.03-854.85%
TECHBio-Techne Corp68.59-872.51%
VCELVericel Corp80.63-1008.04%
PHARPharming Group N.V.87.74-1088.12%
ALNYAlnylam Pharmaceuticals Inc124.93-1506.99%
TLXTelix Pharmaceuticals Ltd139.89-1675.44%
CORTCorcept Therapeutics Inc158.39-1883.77%